IMPACT OF A PRIOR AUTHORIZATION FOR PREGABALIN ON HEALTH PLAN DRUG EXPENDITURES

被引：0
|
作者：
Bazalo, G. [1 ]
Weiss, R. C. [2 ]
Joshi, A., V [3 ]
机构：
[1] Managed Solut LLC, Conifer, CO USA
[2] Managed Solut LLC, Randolph, NJ USA
[3] Pfizer Inc, New York, NY USA
来源：
VALUE IN HEALTH | 2010年 / 13卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)73008-4
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A206 / A206
页数：1
相关论文
共 50 条
  • [1] Impact of a Prior Authorization for Pregabalin on Health Plan Drug Expenditures
    Bazalo, Gary
    Weiss, Richard C.
    Joshi, Ashish V.
    AMERICAN JOURNAL OF MANAGED CARE, 2010, 16 (05): : S154 - S159
  • [2] Effects of a Medicaid Prior Authorization Policy for Pregabalin
    Margolis, Jay M.
    Johnston, Stephen S.
    Chu, Bong-Chul
    Onukwugha, Eberechukwu
    Hvidsten, Kyle
    Alvir, Jose
    Rossi, Joseph G.
    Mullins, C. Daniel
    AMERICAN JOURNAL OF MANAGED CARE, 2009, 15 (10): : E95 - E102
  • [3] Healthcare Utilization and Cost Effects of Prior Authorization for Pregabalin in Commercial Health Plans
    Margolis, Jay M.
    Cao, Zhun
    Onukwugha, Eberechukwu
    Sanchez, Robert J.
    Alvir, Jose
    Joshi, Ashish V.
    Mullins, C. Daniel
    AMERICAN JOURNAL OF MANAGED CARE, 2010, 16 (06): : 447 - 456
  • [4] The Impact of Commercial Health Plan Prior Authorization Programs on the Utilization of Services for Low Back Pain
    Goodman, Robert M.
    Powell, Corey C.
    Park, Paul
    SPINE, 2016, 41 (09) : 810 - 815
  • [5] The Impact of Commercial Health Plan Prior Authorization Programs on the Utilization of Services for Low Back Pain
    Park, Paul
    Goodman, Robert
    Powell, Corey
    JOURNAL OF NEUROSURGERY, 2016, 124 (04) : A1179 - A1180
  • [6] Clinical prior authorization program: A strategy for controlling drug expenditures among patients with insomnia
    Sun, SX
    McMurray, J
    Jacobsen, V
    Fuldeore, M
    Lee, K
    Bertram, C
    VALUE IN HEALTH, 2005, 8 (03) : 324 - 324
  • [7] Multiple prior years of health expenditures and Medicare health plan choice.
    Maciejewski M.L.
    Dowd B.
    O'Connor H.
    International Journal of Health Care Finance and Economics, 2004, 4 (3): : 247 - 261
  • [8] IMPACT OF NOVOLOG EXTENDED DRUG STABILITY ON HEALTH PLAN EXPENDITURES FOR INSULIN AND SUPPLIES IN PUMP USERS
    Bazalo, G.
    Weiss, R. C.
    Bouchard, J.
    Aagren, M.
    VALUE IN HEALTH, 2010, 13 (03) : A57 - A57
  • [9] Retrospective Database Analysis of the Impact of Prior Authorization for Type 2 Diabetes Medications on Health Care Costs in a Medicare Advantage Prescription Drug Plan Population
    Bergeson, Joette Gdovin
    Worley, Karen
    Louder, Anthony
    Ward, Melea
    Graham, John
    JOURNAL OF MANAGED CARE PHARMACY, 2013, 19 (05): : 374 - 384
  • [10] The impact of prior authorization on outpatient utilization in managed behavioral health plans
    Liu, XF
    Sturm, R
    Cuffel, BJ
    MEDICAL CARE RESEARCH AND REVIEW, 2000, 57 (02) : 182 - 195
12345